• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Curevac N.V. (NQ: CVAC )

    2.480 +0.040 (+1.64%)
    Streaming Delayed Price Updated: 10:30 AM EDT, Apr 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 58,833
    Open 2.470
    Bid (Size) 2.470 (7)
    Ask (Size) 2.480 (3)
    Prev. Close 2.440
    Today's Range 2.400 - 2.490
    52wk Range 2.440 - 12.36
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024
    Via ACCESSWIRE
    CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines
    Via ACCESSWIRE

    Performance

    YTD
    -40.81%
    -40.81%
    1 Month
    -15.65%
    -15.65%
    3 Month
    -31.87%
    -31.87%
    6 Month
    -54.24%
    -54.24%
    1 Year
    -69.27%
    -69.27%

    More News

    Read More
    Bill Gates Called For A 'Universal Flu Vaccine,' Now The CDC Director Says The Organization Is 'Activated' After Issuing Bird Flu Alert
    Via Benzinga
    CureVac, GS Partner Release Data On Influenza Vaccine Study
    Via Benzinga
    CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK
    Via ACCESSWIRE
    CureVac Announces Financial Results for the Third Quarter and First Nine Months of 2023 and Provides Business Update
    Via ACCESSWIRE
    Why Biopharmaceutical Player CureVac Shares Are Rising Today
    Via Benzinga
    CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform
    Via ACCESSWIRE
    Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Why Is COVID-19 Vaccine Player CureVac Stock Plummeting Today?
    Via Benzinga
    Topics Intellectual Property Lawsuit
    Exposures COVID-19 Financial Intellectual Property
    Bluebird Bio, Vertex Energy And Other Big Stocks Moving Lower On Tuesday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    CureVac Announces Decision of German Federal Patent Court in Broad Patent Litigation with BioNTech SE
    Via ACCESSWIRE
    Acuitas Challenges CureVac in Legal Tussle Over COVID-19 Vaccine Technology
    Via Benzinga
    Topics Intellectual Property Lawsuit
    Exposures COVID-19 Financial Intellectual Property
    Earnings Scheduled For November 14, 2023
    Via Benzinga
    CureVac Announces Solid Progress in Phase 2 COVID-19 and Seasonal Flu Clinical Development Programs in Collaboration with GSK
    Via ACCESSWIRE
    Why CureVac Stock Plunged Today
    Via The Motley Fool
    Topics Lawsuit
    Exposures Financial Legal
    3 Stocks to Buy For the COVID Resurgence
    Via MarketBeat
    Exposures COVID-19 Product Safety
    CureVac Announces Financial Results for the Second Quarter and First Half of 2023 and Provides Business Update
    Via ACCESSWIRE
    Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    CureVac Announces Dosing of First Participant in Phase 2 Study of Modified COVID-19 mRNA Vaccine Candidates Developed in Collaboration with GSK
    Via ACCESSWIRE
    CureVac Announces Update to the Management Team
    Via ACCESSWIRE
    CureVac Strengthens Ongoing Patent Litigations Bringing Additional Cases Under New Intellectual Property Rights
    Via ACCESSWIRE
    Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Why Shares of CureVac Jumped This Week
    Via The Motley Fool
    Why CureVac Stock Leaped 12% Higher Today
    Via The Motley Fool
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.